7-[4-(Trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one is a chemical compound characterized by its complex structure, which includes a benzoxazepine core. This compound features a tetrahydro configuration, indicating the presence of a saturated ring system, and a phenyl group substituted with a trifluoromethoxy group, which enhances its lipophilicity and potentially its biological activity. The trifluoromethoxy group is known for imparting unique electronic properties, which can influence the compound's reactivity and interaction with biological targets. The presence of the carbonyl group in the benzoxazepine structure suggests potential for hydrogen bonding and reactivity in various chemical environments. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of new therapeutic agents. Its specific characteristics, such as solubility, stability, and reactivity, would depend on the surrounding conditions and the presence of other functional groups in a given formulation or reaction.

7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one

1430092-39-9: 7-[4-(Trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one is a chemical compound characterized by its complex structure, which includes a benzoxazepine core. This compound features a tetrahydro configuration, indicating the presence of a saturated ring system, and a phenyl group substituted with a trifluoromethoxy group, which enhances its lipophilicity and potentially its biological activity. The trifluoromethoxy group is known for imparting unique electronic properties, which can influence the compound's reactivity and interaction with biological targets. The presence of the carbonyl group in the benzoxazepine structure suggests potential for hydrogen bonding and reactivity in various chemical environments. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry, particularly in the development of new therapeutic agents. Its specific characteristics, such as solubility, stability, and reactivity, would depend on the surrounding conditions and the presence of other functional groups in a given formulation or reaction.

CAS 1430092-39-9

7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one

7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one

Ref: IN-DA00IL96

7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one

Ref: 10-F519244